PDS Planning Inc Boosts Stock Position in Relx Plc $RELX

PDS Planning Inc lifted its position in shares of Relx Plc (NYSE:RELX) by 6.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,041 shares of the technology company’s stock after purchasing an additional 566 shares during the period. PDS Planning Inc’s holdings in Relx were worth $491,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of RELX. Carnegie Investment Counsel purchased a new stake in shares of Relx during the first quarter worth about $16,026,000. Ameriprise Financial Inc. boosted its holdings in shares of Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock worth $154,129,000 after purchasing an additional 234,094 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Relx by 103.4% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock worth $22,400,000 after purchasing an additional 225,947 shares during the period. Northern Trust Corp boosted its holdings in shares of Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after purchasing an additional 202,509 shares during the period. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of Relx by 304.6% during the second quarter. Janney Montgomery Scott LLC now owns 242,649 shares of the technology company’s stock worth $13,186,000 after purchasing an additional 182,673 shares during the period. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

RELX has been the subject of several research analyst reports. Morgan Stanley restated an “overweight” rating on shares of Relx in a report on Thursday, September 11th. Weiss Ratings restated a “buy (b)” rating on shares of Relx in a report on Wednesday. Barclays restated an “overweight” rating on shares of Relx in a report on Tuesday. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Finally, Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the stock. According to MarketBeat.com, Relx presently has a consensus rating of “Buy”.

Relx Price Performance

RELX stock opened at $44.80 on Friday. The firm has a 50 day moving average price of $47.22 and a 200-day moving average price of $50.81. Relx Plc has a 52-week low of $44.19 and a 52-week high of $56.33. The firm has a market capitalization of $81.87 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 2.92 and a beta of 0.87. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47.

Relx Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were issued a dividend of $0.2634 per share. This represents a dividend yield of 170.0%. The ex-dividend date was Friday, August 8th. Relx’s dividend payout ratio (DPR) is presently 28.49%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.